Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enobosarm + Abemaciclib in ER+ HER2- Metastatic Breast Cancer
NCT05065411Phase 3Terminated
- Sponsor
- Veru Inc.
- Start
- Apr 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enobosarm in breast cancer, sponsored by Veru Inc.. Started Apr 2022; status: terminated.
02
Drugs
enobosarm
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05065411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05065411.